148OAssessment of tumor response, alpha-fetoprotein (AFP) response, and time to progression (TTP) in the phase III CELESTIAL trial of cabozantinib (C) versus placebo (P) in advanced hepatocellular carcinoma (HCC)
Yau, T, Merle, P, Rimassa, L, Ryoo, B-Y, Cicin, I, Harris, W P, Banu, E, Sarker, D, Tan, B, van Vlierberghe, H, Sen, S, Love, C, Cheng, A-L, Meyer, T, Kelley, R K, Abou-Alfa, G KVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy432
Date:
November, 2018
File:
PDF, 92 KB
english, 2018